Author Archives: Dan Gillmor

There’s a wildly speculative piece over at The Register about a linkup between IBM and Apple, stemming from IBM’s much-reported but still not confirmed decision to spin off its PC division. Quoth El Reg: “(A)n even better and more audacious … Continue reading →

A demo for class: two famous Hong Kong buildings. Comments

Many thanks to Kevin McAllister, who posted this page of links to the websites I mentioned in We the Media. The book’s online in a PDF format, but he took the time to put in the hyperlinks in the “website … Continue reading →

For many years, a Washington lobbying organization called the Computer and Communications Industry Association took a stand for competition and innovation in the technology and communications marketplaces. In the courts of law and public opinion, the CCIA challenged the practices … Continue reading →

Here’s a quick (and not very professional) photograph of some of the people who came to my talk this evening. I plan to delete this after showing it to the group. Comments

I’m giving a demonstration to some visitors from China. Comments

Financial Times: Microsoft critic given $9.75 million in deal. The landmark antitrust settlement this month between Microsoft and the Computer and Communications Industry Association, one of its oldest adversaries, resulted in a $9.75m payment to the CCIA’s top official, according … Continue reading →

Boston Herald: Economic `Armageddon’ predicted. Stephen Roach, the chief economist at investment banking giant Morgan Stanley, has a public reputation for being bearish. But you should hear what he’s saying in private. Roach met select groups of fund managers downtown … Continue reading →

Mercury News: Oracle wins backing of 61% in PeopleSoft offer. PeopleSoft’s board has shown no signs of backing down from its opposition to the $24-a-share deal, putting it on the controversial path of defying the will of a majority of … Continue reading →

AP: FDA Saw Problems at Vaccine Plant in 2003. Documents provided by the FDA to a congressional committee show that inspectors uncovered contamination and unsanitary conditions at a Chiron Corp. flu vaccine manufacturing plant in England in 2003. Yet the … Continue reading →